SlideShare a Scribd company logo
 
Serum Selenium Level and Prostate Cancer: A Case-Control Study   G.POURMAND, M.D. Professor of Urology, Urology Research Center, Medical Sciences/University of Tehran  Tehran, IRAN
Background  Essential trace element (1)      Meat, seafood, grains, eggs and etc (1)    Chemo-protective effects (2) 1- Combs GF Jr. 2004, Br J Cancer; Klein EA. 2004, J Urol; Platz EA and Helzlsouer KJ. 2001, Epidemiol Rev.  2- Redman C and Lee S. 1998, Cancer lett; Combs GF Jr. 2005, J Nutr; Kim YS and Milner J. 2001, Nutr Cancer.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
   Various parts of the world        Other studies   ≠  Other reports
Objective Does selenium have any effect on  Prostate Cancer?
Materials and Methods ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Result  ,[object Object]
Comparison of demographic and baseline characteristics of patients in both groups;  (values are mean±SD)
Characteristic  Cancer  Group  (n=62) Control  Group  (n=68) P value  Age (yrs) 70.0±7.6 68.1±8.1 0.17 BMI (kg/m 2 ) 24.2±2.1 24.3±3.0 0.86 Se. Level (μg/L) 66.3±17.7 77.5±22.5 <0.002 FH of PCa 2(3.2%) 1(1.5%) 0.60 Smoking 0.46 Never 45(72.6%) 50(73.5%) Past  12(19.4%) 9(13.2%) Current  5(8.1%) 9(13.2%) PSA (ng/ml) 23.9±25.8 5.7±4.4 <0.001
Characteristic  Cancer  Group  (n=62) Control  Group  (n=68) P value  Tumor Grading  - Low (GS<7) 17(27.4%) - Intermediate (GS=7) 22(35.5%) - High (GS>7) 23(37.1%) - Treatment procedure   Surgery  24(38.7%) - Hormonal therapy  36(58.1%) - Radiotherapy  2(3.2%) - Nutritional selenium consumption  8.54±1.84 8.45±1.78 0.78
Association between age, BMI, smoking, serum selenium level and the risk of prostate cancer  Variable  OR  95%CI P value  Age (yrs) 1.037 0.99-1.09 0.134 BMI (kg/m2) 1.000 0.87-1.15 0.999 Smoking habit  Never  1 - - Former  0.935 0.34-2.26 0.896 Current  0.475 0.14-1.63 0.237 Selenium level (μg/L) <67.7 1 - - 67.7-89.29 0.478 0.21-1.10 0.084 ≥ 89.3 0.160 0.055-0.470 0.001
Correlation coefficients between serum selenium level and age, BMI, and PSA in controls group  Variable  Mean±SD Pearson r  P value  Age (yrs) 68.1±8.1 -0.19 0.12 BMI (kg/m 2 ) 24.3±3 -0.03 0.78 PSA (ng/ml) 5.75±4.4 0.03 0.83
 
Discussion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 SELECT Trial     Plasma selenium decreases by aging     Role in progression     Smoking and selenium-prostate cancer association
Conclusion     Our study supports the hypothesis that selenium may protect prostate cancer      Supplementary selenium     Selenium-rich foods
Thank you for your time and attention

More Related Content

What's hot

Management of metastatic colorectal cancer
Management of metastatic colorectal cancerManagement of metastatic colorectal cancer
Management of metastatic colorectal cancer
Mohamed Abdulla
 
Expanding treatment platform in m crc bayer - asyut 2018
Expanding treatment platform in m crc   bayer - asyut 2018Expanding treatment platform in m crc   bayer - asyut 2018
Expanding treatment platform in m crc bayer - asyut 2018
Mohamed Abdulla
 
Liver limited Metastatic Colorectal Cancer. Case Presentation
Liver limited Metastatic Colorectal Cancer. Case PresentationLiver limited Metastatic Colorectal Cancer. Case Presentation
Liver limited Metastatic Colorectal Cancer. Case Presentation
Mohamed Abdulla
 
metastatic colorectal cancer; a new chapter in the story
metastatic colorectal cancer; a new chapter in the storymetastatic colorectal cancer; a new chapter in the story
metastatic colorectal cancer; a new chapter in the story
Mohamed Abdulla
 
Ueda2016 diabetes &amp; cancer - mesbah kamel
Ueda2016 diabetes &amp; cancer - mesbah kamelUeda2016 diabetes &amp; cancer - mesbah kamel
Ueda2016 diabetes &amp; cancer - mesbah kamel
ueda2015
 
Gene Profiling in Clinical Oncology - Slide 5 - R. Labianca - What do we do t...
Gene Profiling in Clinical Oncology - Slide 5 - R. Labianca - What do we do t...Gene Profiling in Clinical Oncology - Slide 5 - R. Labianca - What do we do t...
Gene Profiling in Clinical Oncology - Slide 5 - R. Labianca - What do we do t...European School of Oncology
 
Everything you need to know about moa of bone targeted agents amgen 2017
Everything you need to know about moa of bone targeted agents amgen 2017Everything you need to know about moa of bone targeted agents amgen 2017
Everything you need to know about moa of bone targeted agents amgen 2017
Mohamed Abdulla
 
Nsclc slide deck
Nsclc slide deckNsclc slide deck
Nsclc slide deck
PLMMedical
 
Does Race Impact Postoperative Outcomes in Low Risk Prostate 10.23.08
Does Race Impact Postoperative Outcomes in Low Risk Prostate 10.23.08Does Race Impact Postoperative Outcomes in Low Risk Prostate 10.23.08
Does Race Impact Postoperative Outcomes in Low Risk Prostate 10.23.08
Leonard Davis Institute of Health Economics
 
The Diabetes - Cancer Connection
The Diabetes - Cancer ConnectionThe Diabetes - Cancer Connection
The Diabetes - Cancer Connection
Summit Health
 
CRPC management
CRPC managementCRPC management
CRPC management
Mohamed Abdulla
 
ueda2012 diabetes and cancer-d.i.daskalova
ueda2012 diabetes and cancer-d.i.daskalovaueda2012 diabetes and cancer-d.i.daskalova
ueda2012 diabetes and cancer-d.i.daskalova
ueda2015
 
Individualizing Therapy For Patients With Advanced Rcc
Individualizing Therapy For Patients With Advanced RccIndividualizing Therapy For Patients With Advanced Rcc
Individualizing Therapy For Patients With Advanced Rccfondas vakalis
 
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...
isrodoy isr
 
Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...
Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...
Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...European School of Oncology
 
Clasificación de riesgo en renal metastásico
Clasificación de riesgo en renal metastásicoClasificación de riesgo en renal metastásico
Clasificación de riesgo en renal metastásico
Mauricio Lema
 
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simba Takuva
 
Survivorship Issues Genetics 2016
Survivorship Issues Genetics 2016Survivorship Issues Genetics 2016
Survivorship Issues Genetics 2016
OSUCCC - James
 

What's hot (20)

Management of metastatic colorectal cancer
Management of metastatic colorectal cancerManagement of metastatic colorectal cancer
Management of metastatic colorectal cancer
 
Expanding treatment platform in m crc bayer - asyut 2018
Expanding treatment platform in m crc   bayer - asyut 2018Expanding treatment platform in m crc   bayer - asyut 2018
Expanding treatment platform in m crc bayer - asyut 2018
 
Liver limited Metastatic Colorectal Cancer. Case Presentation
Liver limited Metastatic Colorectal Cancer. Case PresentationLiver limited Metastatic Colorectal Cancer. Case Presentation
Liver limited Metastatic Colorectal Cancer. Case Presentation
 
metastatic colorectal cancer; a new chapter in the story
metastatic colorectal cancer; a new chapter in the storymetastatic colorectal cancer; a new chapter in the story
metastatic colorectal cancer; a new chapter in the story
 
Mc tiernan opac2013
Mc tiernan opac2013Mc tiernan opac2013
Mc tiernan opac2013
 
Ueda2016 diabetes &amp; cancer - mesbah kamel
Ueda2016 diabetes &amp; cancer - mesbah kamelUeda2016 diabetes &amp; cancer - mesbah kamel
Ueda2016 diabetes &amp; cancer - mesbah kamel
 
Gene Profiling in Clinical Oncology - Slide 5 - R. Labianca - What do we do t...
Gene Profiling in Clinical Oncology - Slide 5 - R. Labianca - What do we do t...Gene Profiling in Clinical Oncology - Slide 5 - R. Labianca - What do we do t...
Gene Profiling in Clinical Oncology - Slide 5 - R. Labianca - What do we do t...
 
Everything you need to know about moa of bone targeted agents amgen 2017
Everything you need to know about moa of bone targeted agents amgen 2017Everything you need to know about moa of bone targeted agents amgen 2017
Everything you need to know about moa of bone targeted agents amgen 2017
 
Nsclc slide deck
Nsclc slide deckNsclc slide deck
Nsclc slide deck
 
Does Race Impact Postoperative Outcomes in Low Risk Prostate 10.23.08
Does Race Impact Postoperative Outcomes in Low Risk Prostate 10.23.08Does Race Impact Postoperative Outcomes in Low Risk Prostate 10.23.08
Does Race Impact Postoperative Outcomes in Low Risk Prostate 10.23.08
 
The Diabetes - Cancer Connection
The Diabetes - Cancer ConnectionThe Diabetes - Cancer Connection
The Diabetes - Cancer Connection
 
CRPC management
CRPC managementCRPC management
CRPC management
 
ueda2012 diabetes and cancer-d.i.daskalova
ueda2012 diabetes and cancer-d.i.daskalovaueda2012 diabetes and cancer-d.i.daskalova
ueda2012 diabetes and cancer-d.i.daskalova
 
Individualizing Therapy For Patients With Advanced Rcc
Individualizing Therapy For Patients With Advanced RccIndividualizing Therapy For Patients With Advanced Rcc
Individualizing Therapy For Patients With Advanced Rcc
 
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...
 
Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...
Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...
Gene Profiling in Clinical Oncology - Slide 2 - T. Le Chevalier - Treatment o...
 
G. Ceresoli - Lung cancer - State of the art
G. Ceresoli - Lung cancer - State of the artG. Ceresoli - Lung cancer - State of the art
G. Ceresoli - Lung cancer - State of the art
 
Clasificación de riesgo en renal metastásico
Clasificación de riesgo en renal metastásicoClasificación de riesgo en renal metastásico
Clasificación de riesgo en renal metastásico
 
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
 
Survivorship Issues Genetics 2016
Survivorship Issues Genetics 2016Survivorship Issues Genetics 2016
Survivorship Issues Genetics 2016
 

Viewers also liked

Nicb Research Overview
Nicb Research OverviewNicb Research Overview
Minerals 2
Minerals 2Minerals 2
Minerals 2
Sidra Javed
 
Nutrition12
Nutrition12Nutrition12
Nutrition12
irisyang
 
Selenium compounds boost immune system to fight against cancer
Selenium compounds boost immune system to fight against cancerSelenium compounds boost immune system to fight against cancer
Selenium compounds boost immune system to fight against cancer
Amna Jalil
 
Trace elements and dental health
Trace elements and dental healthTrace elements and dental health
Trace elements and dental health
Marwan Ramadan,Dentist
 
Antioxidants and their therapeutic implications
Antioxidants and their therapeutic implicationsAntioxidants and their therapeutic implications
Antioxidants and their therapeutic implications
Manish Kumar
 

Viewers also liked (7)

Nicb Research Overview
Nicb Research OverviewNicb Research Overview
Nicb Research Overview
 
Minerals 2
Minerals 2Minerals 2
Minerals 2
 
Nutrition12
Nutrition12Nutrition12
Nutrition12
 
Selenium compounds boost immune system to fight against cancer
Selenium compounds boost immune system to fight against cancerSelenium compounds boost immune system to fight against cancer
Selenium compounds boost immune system to fight against cancer
 
selenium
seleniumselenium
selenium
 
Trace elements and dental health
Trace elements and dental healthTrace elements and dental health
Trace elements and dental health
 
Antioxidants and their therapeutic implications
Antioxidants and their therapeutic implicationsAntioxidants and their therapeutic implications
Antioxidants and their therapeutic implications
 

Similar to Selenium

Treatment of Platinum sensitive relapsed carcinoma ovary
Treatment of Platinum sensitive relapsed carcinoma ovaryTreatment of Platinum sensitive relapsed carcinoma ovary
Treatment of Platinum sensitive relapsed carcinoma ovary
Alok Gupta
 
Beyond lhrh analogues in hormone refractory prostate cancer amman - 2016
Beyond lhrh analogues in hormone refractory prostate cancer   amman - 2016Beyond lhrh analogues in hormone refractory prostate cancer   amman - 2016
Beyond lhrh analogues in hormone refractory prostate cancer amman - 2016
Mohamed Abdulla
 
Estudio Paramount cáncer de pulmón 2014
Estudio Paramount cáncer de pulmón 2014Estudio Paramount cáncer de pulmón 2014
Estudio Paramount cáncer de pulmón 2014Martín Lázaro
 
NY Prostate Cancer Conference - M.H. Hussain - Session 5: Predicting response...
NY Prostate Cancer Conference - M.H. Hussain - Session 5: Predicting response...NY Prostate Cancer Conference - M.H. Hussain - Session 5: Predicting response...
NY Prostate Cancer Conference - M.H. Hussain - Session 5: Predicting response...European School of Oncology
 
Renal Cell Carcinoma A New Standard Of Care
Renal Cell Carcinoma A New Standard Of CareRenal Cell Carcinoma A New Standard Of Care
Renal Cell Carcinoma A New Standard Of Carefondas vakalis
 
Neuroendocrine tumors in 2015
Neuroendocrine tumors in 2015Neuroendocrine tumors in 2015
Neuroendocrine tumors in 2015
Mohamed Abdulla
 
INMUNOTERPAPIA EN CANCER DE VIAS BILIARES AVANZADO.pptx
INMUNOTERPAPIA EN CANCER DE VIAS BILIARES AVANZADO.pptxINMUNOTERPAPIA EN CANCER DE VIAS BILIARES AVANZADO.pptx
INMUNOTERPAPIA EN CANCER DE VIAS BILIARES AVANZADO.pptx
ResidenteOncologiaMd
 
Management of crpc
Management of crpcManagement of crpc
Management of crpc
Mohamed Abdulla
 
Prostate cancer nemrock 2015 sanofi
Prostate cancer nemrock 2015   sanofiProstate cancer nemrock 2015   sanofi
Prostate cancer nemrock 2015 sanofiMohamed Abdulla
 
Gastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET managementGastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET management
Chandan K Das
 
Cetuximab in scchn how far we go?
Cetuximab in scchn  how far we go?Cetuximab in scchn  how far we go?
Cetuximab in scchn how far we go?
Mohamed Abdulla
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...European School of Oncology
 
Capacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCC
Capacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCCCapacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCC
Capacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCC
Mauricio Lema
 
Continuous Update Project and Systematic Literature Reviews (Conference: Diet...
Continuous Update Project and Systematic Literature Reviews (Conference: Diet...Continuous Update Project and Systematic Literature Reviews (Conference: Diet...
Continuous Update Project and Systematic Literature Reviews (Conference: Diet...
World Cancer Research Fund International
 
Management of colorectal cancer
Management of colorectal cancer Management of colorectal cancer
Management of colorectal cancer
Mohamed Abdulla
 
Asco-cim.linfoma.pptx
Asco-cim.linfoma.pptxAsco-cim.linfoma.pptx
Asco-cim.linfoma.pptx
RobertojesusPerezdel1
 

Similar to Selenium (20)

Treatment of Platinum sensitive relapsed carcinoma ovary
Treatment of Platinum sensitive relapsed carcinoma ovaryTreatment of Platinum sensitive relapsed carcinoma ovary
Treatment of Platinum sensitive relapsed carcinoma ovary
 
Beyond lhrh analogues in hormone refractory prostate cancer amman - 2016
Beyond lhrh analogues in hormone refractory prostate cancer   amman - 2016Beyond lhrh analogues in hormone refractory prostate cancer   amman - 2016
Beyond lhrh analogues in hormone refractory prostate cancer amman - 2016
 
Estudio Paramount cáncer de pulmón 2014
Estudio Paramount cáncer de pulmón 2014Estudio Paramount cáncer de pulmón 2014
Estudio Paramount cáncer de pulmón 2014
 
2 predicting response to adt msk.eso 4.3.2011
2 predicting response to adt msk.eso 4.3.20112 predicting response to adt msk.eso 4.3.2011
2 predicting response to adt msk.eso 4.3.2011
 
NY Prostate Cancer Conference - M.H. Hussain - Session 5: Predicting response...
NY Prostate Cancer Conference - M.H. Hussain - Session 5: Predicting response...NY Prostate Cancer Conference - M.H. Hussain - Session 5: Predicting response...
NY Prostate Cancer Conference - M.H. Hussain - Session 5: Predicting response...
 
Renal Cell Carcinoma A New Standard Of Care
Renal Cell Carcinoma A New Standard Of CareRenal Cell Carcinoma A New Standard Of Care
Renal Cell Carcinoma A New Standard Of Care
 
Neuroendocrine tumors in 2015
Neuroendocrine tumors in 2015Neuroendocrine tumors in 2015
Neuroendocrine tumors in 2015
 
INMUNOTERPAPIA EN CANCER DE VIAS BILIARES AVANZADO.pptx
INMUNOTERPAPIA EN CANCER DE VIAS BILIARES AVANZADO.pptxINMUNOTERPAPIA EN CANCER DE VIAS BILIARES AVANZADO.pptx
INMUNOTERPAPIA EN CANCER DE VIAS BILIARES AVANZADO.pptx
 
Management of crpc
Management of crpcManagement of crpc
Management of crpc
 
7 capdevila
7 capdevila7 capdevila
7 capdevila
 
HCC20121001
HCC20121001 HCC20121001
HCC20121001
 
Prostate cancer nemrock 2015 sanofi
Prostate cancer nemrock 2015   sanofiProstate cancer nemrock 2015   sanofi
Prostate cancer nemrock 2015 sanofi
 
Gastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET managementGastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET management
 
Prostate 101
Prostate 101Prostate 101
Prostate 101
 
Cetuximab in scchn how far we go?
Cetuximab in scchn  how far we go?Cetuximab in scchn  how far we go?
Cetuximab in scchn how far we go?
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
 
Capacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCC
Capacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCCCapacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCC
Capacitación fuerza de ventas BMS Nivo/Ipi 1ra línea RCC
 
Continuous Update Project and Systematic Literature Reviews (Conference: Diet...
Continuous Update Project and Systematic Literature Reviews (Conference: Diet...Continuous Update Project and Systematic Literature Reviews (Conference: Diet...
Continuous Update Project and Systematic Literature Reviews (Conference: Diet...
 
Management of colorectal cancer
Management of colorectal cancer Management of colorectal cancer
Management of colorectal cancer
 
Asco-cim.linfoma.pptx
Asco-cim.linfoma.pptxAsco-cim.linfoma.pptx
Asco-cim.linfoma.pptx
 

More from Patricia Khashayar (20)

Natural remedies treat chronic wounds
Natural remedies treat chronic woundsNatural remedies treat chronic wounds
Natural remedies treat chronic wounds
 
Recommended food for Ramadan
Recommended food for RamadanRecommended food for Ramadan
Recommended food for Ramadan
 
sterile water
sterile watersterile water
sterile water
 
plastic surgeon
plastic surgeonplastic surgeon
plastic surgeon
 
Alternative medicine Coconut
Alternative medicine CoconutAlternative medicine Coconut
Alternative medicine Coconut
 
War-related health problems in Iraq
War-related health problems in IraqWar-related health problems in Iraq
War-related health problems in Iraq
 
Alternative medicine Carrot
Alternative medicine CarrotAlternative medicine Carrot
Alternative medicine Carrot
 
Alternative medicine Apple
Alternative medicine AppleAlternative medicine Apple
Alternative medicine Apple
 
infertility2
infertility2infertility2
infertility2
 
Alternative medicine Cinnamon
Alternative medicine CinnamonAlternative medicine Cinnamon
Alternative medicine Cinnamon
 
alternative medicine borage
alternative medicine boragealternative medicine borage
alternative medicine borage
 
Nanotalk last
Nanotalk lastNanotalk last
Nanotalk last
 
Shakibaei takes his final bow
Shakibaei takes his final bowShakibaei takes his final bow
Shakibaei takes his final bow
 
Alternative medicine Pomgrenate
Alternative medicine PomgrenateAlternative medicine Pomgrenate
Alternative medicine Pomgrenate
 
JC
JCJC
JC
 
Kaposi sarcoma
Kaposi sarcomaKaposi sarcoma
Kaposi sarcoma
 
A revolution in Chinese stem cell technology
A revolution in Chinese stem cell technologyA revolution in Chinese stem cell technology
A revolution in Chinese stem cell technology
 
Gabapentine
GabapentineGabapentine
Gabapentine
 
computer
computercomputer
computer
 
Alternative medicine Caraway
Alternative medicine CarawayAlternative medicine Caraway
Alternative medicine Caraway
 

Recently uploaded

PCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase TeamPCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase Team
ControlCase
 
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
Product School
 
UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4
DianaGray10
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
Prayukth K V
 
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
James Anderson
 
Leading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdfLeading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdf
OnBoard
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
ThousandEyes
 
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
Product School
 
Essentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with ParametersEssentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with Parameters
Safe Software
 
Monitoring Java Application Security with JDK Tools and JFR Events
Monitoring Java Application Security with JDK Tools and JFR EventsMonitoring Java Application Security with JDK Tools and JFR Events
Monitoring Java Application Security with JDK Tools and JFR Events
Ana-Maria Mihalceanu
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
Guy Korland
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
Laura Byrne
 
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMsTo Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
Paul Groth
 
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdfFIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance
 
Generating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using SmithyGenerating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using Smithy
g2nightmarescribd
 
UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3
DianaGray10
 
Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*
Frank van Harmelen
 
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
UiPathCommunity
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
BookNet Canada
 
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdfFIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance
 

Recently uploaded (20)

PCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase TeamPCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase Team
 
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
From Daily Decisions to Bottom Line: Connecting Product Work to Revenue by VP...
 
UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
 
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
 
Leading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdfLeading Change strategies and insights for effective change management pdf 1.pdf
Leading Change strategies and insights for effective change management pdf 1.pdf
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
 
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
 
Essentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with ParametersEssentials of Automations: Optimizing FME Workflows with Parameters
Essentials of Automations: Optimizing FME Workflows with Parameters
 
Monitoring Java Application Security with JDK Tools and JFR Events
Monitoring Java Application Security with JDK Tools and JFR EventsMonitoring Java Application Security with JDK Tools and JFR Events
Monitoring Java Application Security with JDK Tools and JFR Events
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
 
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMsTo Graph or Not to Graph Knowledge Graph Architectures and LLMs
To Graph or Not to Graph Knowledge Graph Architectures and LLMs
 
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdfFIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
FIDO Alliance Osaka Seminar: Passkeys at Amazon.pdf
 
Generating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using SmithyGenerating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using Smithy
 
UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3
 
Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*
 
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
 
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdfFIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
 

Selenium

  • 1.  
  • 2. Serum Selenium Level and Prostate Cancer: A Case-Control Study G.POURMAND, M.D. Professor of Urology, Urology Research Center, Medical Sciences/University of Tehran Tehran, IRAN
  • 3. Background  Essential trace element (1)  Meat, seafood, grains, eggs and etc (1)  Chemo-protective effects (2) 1- Combs GF Jr. 2004, Br J Cancer; Klein EA. 2004, J Urol; Platz EA and Helzlsouer KJ. 2001, Epidemiol Rev. 2- Redman C and Lee S. 1998, Cancer lett; Combs GF Jr. 2005, J Nutr; Kim YS and Milner J. 2001, Nutr Cancer.
  • 4.
  • 5. Various parts of the world   Other studies  ≠ Other reports
  • 6. Objective Does selenium have any effect on Prostate Cancer?
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12. Comparison of demographic and baseline characteristics of patients in both groups; (values are mean±SD)
  • 13. Characteristic Cancer Group (n=62) Control Group (n=68) P value Age (yrs) 70.0±7.6 68.1±8.1 0.17 BMI (kg/m 2 ) 24.2±2.1 24.3±3.0 0.86 Se. Level (μg/L) 66.3±17.7 77.5±22.5 <0.002 FH of PCa 2(3.2%) 1(1.5%) 0.60 Smoking 0.46 Never 45(72.6%) 50(73.5%) Past 12(19.4%) 9(13.2%) Current 5(8.1%) 9(13.2%) PSA (ng/ml) 23.9±25.8 5.7±4.4 <0.001
  • 14. Characteristic Cancer Group (n=62) Control Group (n=68) P value Tumor Grading - Low (GS<7) 17(27.4%) - Intermediate (GS=7) 22(35.5%) - High (GS>7) 23(37.1%) - Treatment procedure Surgery 24(38.7%) - Hormonal therapy 36(58.1%) - Radiotherapy 2(3.2%) - Nutritional selenium consumption 8.54±1.84 8.45±1.78 0.78
  • 15. Association between age, BMI, smoking, serum selenium level and the risk of prostate cancer Variable OR 95%CI P value Age (yrs) 1.037 0.99-1.09 0.134 BMI (kg/m2) 1.000 0.87-1.15 0.999 Smoking habit Never 1 - - Former 0.935 0.34-2.26 0.896 Current 0.475 0.14-1.63 0.237 Selenium level (μg/L) <67.7 1 - - 67.7-89.29 0.478 0.21-1.10 0.084 ≥ 89.3 0.160 0.055-0.470 0.001
  • 16. Correlation coefficients between serum selenium level and age, BMI, and PSA in controls group Variable Mean±SD Pearson r P value Age (yrs) 68.1±8.1 -0.19 0.12 BMI (kg/m 2 ) 24.3±3 -0.03 0.78 PSA (ng/ml) 5.75±4.4 0.03 0.83
  • 17.  
  • 18.
  • 19.
  • 20.  SELECT Trial  Plasma selenium decreases by aging  Role in progression  Smoking and selenium-prostate cancer association
  • 21. Conclusion  Our study supports the hypothesis that selenium may protect prostate cancer  Supplementary selenium  Selenium-rich foods
  • 22. Thank you for your time and attention